XML 12 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
RESTATEMENT OF FINANCIAL STATEMENTS
9 Months Ended
Dec. 31, 2011
RESTATEMENT OF FINANCIAL STATEMENTS

NOTE 3 - RESTATEMENT OF FINANCIAL STATEMENTS

 

On April 4, 2012, the Audit Committee of the Board of Directors, based on discussions with management, concluded that the Company would restate its consolidated financial statements for the quarter ended September 30, 2011 in conjunction with the restatement of the financial statements for the year ended March 31, 2011 to correct the following errors:

 

· On February 28, 2011, we acquired a US patent which was accounted for as an acquisition of an asset. However, we recognized as part of the patent’s value the contingent consideration in the form of additional common stock that could be issued to the seller of the patent. Therefore, we overstated the fair value of the patent as recorded as the value for our intangible assets on the balance sheets since the year ended March 31, 2011. As a result, we adjusted the value of the intangible assets to reduce the value of the net intangible asset by $19,154,089 at December 31, 2011; we made an adjustment to reduce the contingent liability associated with the unissued shares by $23,391,902 at December 31, 2011; we adjusted our amortization expense for the US patent based on its restated value by a decreased amount of $1,622,515 for the nine month period ended December 31, 2011; we also made an adjustment to recognize $3,319,135 of derivative liability with an offsetting entry of other expense caused by an amended contract term of the US patent.

 

We also increased by $405,630 the income tax based on the restated net income for the nine month period ended December 31, 2011.

 

The effect of the adjustments on the consolidated statement of operations for the nine month period ended December 31, 2011 is to decrease net income attributable to common shares by $2,102,250. The effect of the adjustments on net income per common share from operations for the nine month period ended December 31, 2011 is a $0.03 decrease in net income per common share.

 

China YCT International Group, Inc.

Consolidated Balance Sheet

 

    December 31, 2011  
    As Previously
Reported
    Adjustments     As Restated  
Assets                        
Current assets:                        
Cash and cash equivalent   $ 18,443,850     $ -     $ 18,443,850  
Prepaid accounts     67,627       -       67,627  
Inventory     2,483,981       -       2,483,981  
Total current assets     20,995,458       -       20,995,458  
Plant, property and equipment, net     9,784,841       -       9,784,841  
Construction in progress     219,752       -       219,752  
Intangible assets, net     70,561,663       (19,154,089 )     51,407,574  
Total assets     101,561,714       (19,154,089 )     82,407,625  
                         
Liabilities and Stockholders’ Equity (Deficit)                        
Liabilities:                        
Current liabilities:                        
Accounts payable     -       -       -  
Tax payable     1,334,321       100,945       1,435,266  
Other payable     1,753,911       2,765,992       4,519,903  
Total current liabilities     3,088,232       2,866,937       5,955,169  
Contingency     23,391,902       (20,072,766 )     3,319,136  
Total liabilities     26,480,134       (17,205,829 )     9,274,305  
                         
Stockholders’ equity                        
Preferred stock, par value $500.00 per share; 45 shares authorized and issued at September 30, 2010 and March 31, 2010     22,500       -       22,500  
Common stock, par value $0.001 per share; 100,000,000 shares authorized, 29,461,304 shares issued and outstanding at March 31, 2010; and 73,731,361 shares issued and outstanding at March 31, 2011.     73,780       -       73,780  
Additional paid-in capital     36,879,643       -       36,879,643  
Statutory reserve     956,633       -       956,633  
Retained earnings     34,255,258       (1,954,822 )     32,300,436  
Accumulated other comprehensive income     2,893,766       6,562       2,900,328  
Total stockholders’ equity     75,081,580       (1,948,260 )     73,133,320  
Total liabilities and stockholders’ equity   $ 101,561,714     $ (19,154,089 )   $ 82,407,625  

 

China YCT International Group, Inc.

Consolidated Income Statement

 

    Nine Months Ended December 31, 2011  
    As Previously
Reported
    Adjustments     As Restated  
Sales Revenue   $ 26,477,760     $ -     $ 26,477,760  
Cost of Goods Sold     11,894,299       -       11,894,299  
Gross Profit     14,583,461       -       14,583,461  
                         
Selling Expenses     2,505,249       -       2,505,249  
G&A Expense     5,651,412       (1,622,515 )     4,028,897  
R&D Expenses     577,514       -       577,514  
Total expense     8,734,175       (1,622,515 )     7,111,660  
Income from operation     5,849,286       1,622,515       7,471,801  
Interest Income (Expense)     209,953       -       209,953  
Other income (Expense)     -       (3,319,135 )     (3,319,135 )
Profit before tax     6,059,239       (1,696,620 )     4,362,619  
Income tax     1,878,207       405,630       2,283,837  
                         
Net income     4,181,032       (2,102,250 )     2,078,782  
 Other comprehensive income                        
Foreign currency translation adjustment     852,472       (4,547 )     847,925  
 Comprehensive income     5,033,504       (2,106,797 )     2,926,707  
                         
Basic and diluted income per common share                        
Basic and Diluted   $ 0.06     $ (0.03 )   $ 0.03  
                         
Weighted average number of common shares outstanding                        
Basic and Diluted     73,780,610       73,780,610       73,780,610  

 

China YCT International Group, Inc.

Consolidated Statement of Cash Flows

 

    Nine Months Ended September 30, 2011  
    As Previously
Reported
    Adjustments     As Restated  
Cash Flows From Operating Activities:                        
Net income   $ 4,181,032     $ (2,102,250 )   $ 2,078,782  
Adjustments to reconcile net income to net cash provided by operating activities:                        
Depreciation and amortization     5,315,531       (1,622,513 )     3,693,018  
Issue of common shares as compensation     -       -       -  
Changes in operating assets and liabilities:                        
Inventory     (2,424,798 )     -       (2,424,798 )
Advance to suppliers                        
Other receivable from related parties     -       -       -  
Accounts payable             -       -  
Taxes payable     (300,480 )     51,802       (248,678 )
Accrued expenses and other payables     1,524,351       6,096,237       7,620,588  
                         
Net cash provided by (used in) operating activities     8,295,636       2,423,276       10,718,912  
                         
Cash flows from investing activities:                        
Addition to plant and equipment     (511,491 )     511,491       -  
Reduction of construction in progress     -       -       -  
Investment in Intagible Assets     -       (14,704,424 )     (14,704,424 )
Prepayment for acquisition of patent     4,107,691       11,426,940       15,534,631  
                         
Net cash provided by (used in) investing activities     3,596,200       (2,765,993 )     830,207  
                         
Effect of exchange rate changes on cash and cash equivalents     505,210       342,716       847,926  
                         
Net increase (decrease) in cash and cash equivalents     12,397,046       -       12,397,046  
                         
Cash and cash equivalents at beginning of period     6,046,804       -       6,046,804  
                         
Cash and cash equivalents at ending of period   $ 18,443,850     $ -     $ 18,443,850